Search Results

Agricola

Record details

Correlates of protection and determinants of SARS-CoV-2 breakthrough infections 1 year after third dose vaccination

• Authors : Martín Pérez, Carla; Aguilar, Ruth; Jiménez, Alfons

• Source: BMC Medicine. March 8, 2024, Vol. 22 Issue 1

Record details

Low pre-infection levels of neutralizing antibody in breakthrough infections after bivalent BA.4-5 vaccine and practical application of dried blood spots.

• Authors : Kawasuji H; Department of Clinical Infectious Diseases, Toyama University Graduate School of Medicine and Pharmaceutical Sciences, Toyama, Japan.; Morinaga Y

• Source: Vaccine [Vaccine] 2024 Jun 04. Date of Electronic Publication: 2024 Jun 04.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Omicron breakthrough infections after triple-dose inactivated COVID-19 vaccination: A comprehensive analysis of antibody and T-cell responses.

• Authors : Xiang T; Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.; Joint International Laboratory of Infection and Immunity, Huazhong University of Science and Technology, Wuhan, China.

Subjects: COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/immunology ; COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/administration & dosage ; SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/immunology COVID-19 breakthrough infectionsSARS-CoV-2 variants

• Source: Immunology [Immunology] 2024 Jun; Vol. 172 (2), pp. 313-327. Date of Electronic Publication: 2024 Mar 10.Publisher: Blackwell Scientific Publications Country of Publication: England NLM ID: 0374672 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Shift in SARS-CoV-2 variants of concern from Delta to Omicron was associated with reduced hospitalizations, increased risk of breakthrough infections but lesser disease severity.

• Authors : Mwendwa F; Department of Pathology and Laboratory Medicine, The Aga Khan University, Karachi, Pakistan.; Kanji A

Subjects: COVID-19*/COVID-19*/COVID-19*/epidemiology ; COVID-19*/COVID-19*/COVID-19*/prevention & control ; COVID-19*/COVID-19*/COVID-19*/virology COVID-19 breakthrough infectionsSARS-CoV-2 variants

• Source: Journal of infection and public health [J Infect Public Health] 2024 Jun; Vol. 17 (6), pp. 1100-1107. Date of Electronic Publication: 2024 May 03.Publisher: Elsevier Country of Publication: England NLM ID: 101487384 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1876-035X

Record details

SARS-CoV-2 breakthrough infections enhance T cell response magnitude, breadth, and epitope repertoire.

• Authors : Tarke A; Center for Vaccine Innovation, La Jolla Institute for Immunology (LJI), La Jolla, CA 92037, USA.; Ramezani-Rad P

• Source: Cell reports. Medicine [Cell Rep Med] 2024 May 17, pp. 101583. Date of Electronic Publication: 2024 May 17.Publisher: Cell Press Country of Publication: United States NLM ID: 101766894 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Clinical and humoral responses after SARS-CoV-2 breakthrough infections in patients with immunosuppressants.

• Authors : Stalman EW; Wieske L ...

• Source: The Journal of allergy and clinical immunology [J Allergy Clin Immunol] 2024 May 17. Date of Electronic Publication: 2024 May 17.Publisher: Mosby Country of Publication: United States NLM ID: 1275002 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6825

Record details

Breakthrough Infections in SARS-CoV-2-Vaccinated Multiple Myeloma Patients Improve Cross-Protection against Omicron Variants.

• Authors : Wagner A; Institute of Specific Prophylaxis and Tropical Medicine, Center of Pathophysiology, Infectiology and Immunology, Medical University Vienna, 1090 Vienna, Austria.; Garner-Spitzer E

• Source: Vaccines [Vaccines (Basel)] 2024 May 09; Vol. 12 (5). Date of Electronic Publication: 2024 May 09.Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101629355 Publication Model: Electronic Cited Medium: Print ISSN: 2076-393X

Record details

Proteomic and Cellular Characterization of Omicron Breakthrough Infections and a Third Homologous or Heterologous Boosting Vaccination in a Longitudinal Cohort.

• Authors : Zhang Y; Department of Infectious Diseases, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, National Medical Center for Infectious Diseases, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China.; Fu Z

• Source: Molecular & cellular proteomics : MCP [Mol Cell Proteomics] 2024 Apr 18; Vol. 23 (6), pp. 100769. Date of Electronic Publication: 2024 Apr 18.Publisher: Elsevier Inc. on behalf of American Society for Biochemistry and Molecular Biology Country of Publication: United States NLM ID: 101125647 Publication

Record details

Agricola

Record details